Xiaofei She

Ms. Xiaofei She

Tongji University, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in The EMBO Journal
Verified
Journal Article
Closed access
XSXiaofei She
Xiaofei She
SSShijun Shen
Shijun Shen
GCGuang Chen
Guang Chen
YGYaqun Gao
Yaqun Gao
JMJunxian Ma
Junxian Ma
HGHua Gao
Hua Gao

14 October 2022 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
GCGuang Chen
Guang Chen
XSXiaofei She
Xiaofei She
YYYanxin Yin
Yanxin Yin
JMJunxian Ma
Junxian Ma
YGYaqun Gao
Yaqun Gao
JFJianmin Fang
Jianmin Fang

1 August 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XSXiaofei She
Xiaofei She
YGYaqun Gao
Yaqun Gao
YZYan Zhao
Yan Zhao
YYYue Yin
Yue Yin
ZDZhewen Dong
Zhewen Dong
Metastasis is the main cause of cancer morbidity and mortality. Cancer stem cells (CSCs) are a rare subpopulation of cancer cells that can drive metastasis. The identification of CSC inhibitors and CSC-related genes is an alluring strategy for suppressing metastasis. Here, we established a simple and repeatable high-throughput CSC inhibitor screening platform that combined tumor sphere formation assays and cell viability assays. Human lung cancer cells were cocultured with 1280 pharmacologically active compounds (FDA-approved). Fifty-four candidate compounds obtained from our screening system completely or partially inhibited tumor sphere formation. A total of 5 of these 54 compounds (prochlorperazine dimaleate, thioridazine hydrochloride, ciproxifan hydrochloride, Ro 25-6981 hydrochloride, and AMN 082) completely inhibited the self-renewal of CSCs without cytotoxicity in vitro via their targets and suppressed lung cancer metastasis in vivo, suggesting that our screening platform is selective and reliable. DRD2, HRH3, and GRIN2B exhibited potent genes promoting CSCs in vitro experiments and clinical datasets. Further validation of the top hit (DRD2) and previously published studies demonstrate that our screening platform is a useful tool for CSC inhibitor and CSC-related gene screening.

25 April 2025 in Advanced Science
Verified
Journal Article
Open access
ZDZhewen Dong
Zhewen Dong
XSXiaofei She
Xiaofei She
JMJunxian Ma
Junxian Ma
QCQian Chen
Qian Chen
YGYaqun Gao
Yaqun Gao
HGHua Gao
Hua Gao
Colorectal cancer is the second most common cause of cancer mortality worldwide, and liver metastasis is the major cause of death of patients with colorectal cancer. Dysfunctional E3 ligase activity has recently been shown to be associated with colorectal cancer. However, the key E3 ligases affecting colorectal cancer liver metastasis remain unknown. Therefore, an shRNA library targeting 156 E3 ubiquitin ligases has been used to perform an in vivo loss‐of‐function screen of a human colorectal cancer cell line in a mouse model of liver metastasis. The screen reveals that neural precursor cell expressed developmentally down‐regulated gene 4‐like (NEDD4L) knockdown promotes colorectal cancer liver metastasis. Mechanistic studies reveal that NEDD4L binds to the PPNAY motif in protein arginine methyltransferase 5 (PRMT5) and ubiquitinates PRMT5 to promote its degradation. PRMT5 degradation attenuates the arginine methylation of AKT1 to inhibit the AKT/mTOR signaling pathway. The effect of NEDD4L decreases colorectal cancer cell proliferation to suppress colonization. This study is the first to show that PRMT5 is a substrate of NEDD4L and reveals not only the metastasis‐inhibiting function of NEDD4L but also a novel mechanism by which NEDD4L prevents colorectal cancer liver metastasis. These findings may provide a new preventive strategy for liver metastasis.